| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 04/08/2009 | EP2044006A1 Insecticidal compounds |
| 04/08/2009 | EP2044004A2 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 04/08/2009 | EP2043993A2 Cyclopentane derivatives as antiglaucoma agents |
| 04/08/2009 | EP2043444A1 Chemical compounds |
| 04/08/2009 | EP1430023B1 Substituied urea retinoid agonists ii |
| 04/08/2009 | CN101405889A Organic electroluminescence element material and organic electroluminescence element using such material |
| 04/08/2009 | CN101404997A Duloxetine salts |
| 04/08/2009 | CN101402629A Synthesis and uses of terthienyl and derivatives thereof |
| 04/08/2009 | CN101402606A Nitrogen heterocyclic ring substituted arylpropenone compounds, preparation method and application thereof |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN101402536A Process for producing compound with steric hindrance biaryl base |
| 04/08/2009 | CN100476583C Ring sulfonium and sulfonium oxide and photoacid generator and photoetching glue containing ring sulfonium and sulfonium oxide |
| 04/08/2009 | CN100475798C Sulfonate derivatives and the use therof as latent acids |
| 04/08/2009 | CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 04/08/2009 | CN100475777C Amide type carboxamide derivative |
| 04/08/2009 | CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/07/2009 | US7514462 ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 04/07/2009 | US7514127 Dibenzofuran derivatives, dibenzothiophene derivatives and fluorene derivatives |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2276278C Amine compounds, their production and use |
| 04/02/2009 | WO2009042970A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 04/02/2009 | WO2009041447A1 5-membered heterocyclic compound |
| 04/02/2009 | US20090088459 Novel biaryl sulfonamide derivatives |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease |
| 04/02/2009 | DE102008047497A1 Zusammensetzung und Verfahren zum Speichern holographischer Daten Composition and method for storing holographic data |
| 04/02/2009 | DE102008047409A1 Storing holographic data, comprises providing holographic storage medium comprising optically transparent substrate (photochemically active polynitrone dye) and irradiating transparent substrate with holographic interference pattern |
| 04/01/2009 | EP2042497A1 Method for producing strontium ranelate and its hydrates |
| 04/01/2009 | EP2042495A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2041110A1 2 -oxyheteroarylamide derivatives as parp inhibitors |
| 04/01/2009 | EP2041089A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 04/01/2009 | EP2041088A1 Glycine transporter-1 inhibitors |
| 04/01/2009 | EP2041073A1 Cxcr2 inhibitors |
| 04/01/2009 | EP2041072A1 Cxcr2 antagonists |
| 04/01/2009 | EP2040697A2 Polymorphic form of duloxetine hydrochloride |
| 04/01/2009 | EP2040688A1 New cxcr2 inhibitors |
| 04/01/2009 | CN101398624A Photo acid generator, chemical amplified photoresist combination comprising the same and relative method |
| 04/01/2009 | CN101397292A Method for producing strontium ranelate and its hydrates |
| 04/01/2009 | CN101397291A Method for preparing 2-cyanoacet-5-substituted thiophenes compound |
| 04/01/2009 | CN100473652C Thienyl substituted hexa-aryl bis-imidazole and method for preparing the same |
| 03/31/2009 | US7511070 Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/31/2009 | US7510822 Aroylmethylsulfonium compounds that are activated by heat or actinic radiation to generate acid |
| 03/31/2009 | US7510219 Threaded connection for oil field applications |
| 03/31/2009 | CA2356121C Novel propargylether derivatives |
| 03/26/2009 | WO2009014267A3 Imidate compound and use thereof for pest control |
| 03/26/2009 | US20090082580 Compositions and methods for storing holographic data |
| 03/26/2009 | US20090082579 2-alkenyl-3-aminothiophene derivative and process for producing thereof |
| 03/26/2009 | US20090082578 Process for the synthesis of strontium ranelate and its hydrates |
| 03/26/2009 | US20090082533 Process for preparing low molecular weight olefin polymers, organometallic transition metal compounds biscyclopentadienyl ligand systems and catalyst systems |
| 03/26/2009 | US20090082308 histone deacetylase inhibitors; antiproliferative; antineoplastic; thioredoxin (TRX)-mediated diseases such as autoimmune, allergy, inflammatory diseases; and neurodegenerative diseases; hydroxamic acid moiety; 6-Carbamoylmethyl-benzo[b]thiophene-2-carboxylic acid (4-amino-1-phenyl-1H-pyrazol-3-yl)amide |
| 03/26/2009 | US20090081684 sequence-selective nucleic acid detection; polythiophenes containing pendant quaternary ammonium groups that are thermostable and autoclavable; use in DNA or RNA electrochemical or optical detection, or purification; diagnosis of infections or disease |
| 03/25/2009 | EP2038253A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/25/2009 | EP1991514A4 Novel anthracene derivative and organic electronic device using the same |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1641740B1 Method for producing an optically active nitro compound |
| 03/25/2009 | CN101391992A Substituted anthracene benzothiophene compounds and preparation method and use thereof |
| 03/25/2009 | CN101391991A Method for preparing duloxetine |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471852C Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers |
| 03/24/2009 | US7507860 Androgen modulators |
| 03/24/2009 | US7507841 Cannabinoid receptor modulator |
| 03/24/2009 | US7507840 Nonlinear optically active compounds that include a pi-donor conjugated to a pi-acceptor through a pi-electron conjugated bridge |
| 03/24/2009 | US7507827 Reacting compounds such as 2, alpha -Dichlorophenyl acetyl chloride with an optically active amino alcohol (-1-(dimethylamino)-2-propanol )to yield mixture of diastereomers |
| 03/24/2009 | US7507817 Glaucome therapy; vision defects |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507545 Ion channel modulating activity method |
| 03/24/2009 | CA2508824C Alpha crystalline form of strontium ranelate, its preparation process, and the pharmaceutical compositions that contain it |
| 03/19/2009 | WO2009035949A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2008131946A3 Substituted amide derivatives |
| 03/19/2009 | US20090076266 Copper-catalyzed c-h bond arylation |
| 03/19/2009 | US20090076101 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090075819 Indanyl- and Tetrahydronaphtyl-amino-thiourea Compounds for Combating Animal Pests |
| 03/19/2009 | US20090074746 Compounds to treat alzheimer's disease |
| 03/19/2009 | CA2697752A1 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/18/2009 | EP2036900A1 Smectic liquid crystal compound |
| 03/18/2009 | EP2035404A1 Crystalline duloxetine hydrochloride |
| 03/18/2009 | EP2035403A1 Crystalline duloxetine hydrochloride |
| 03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
| 03/18/2009 | CN101389621A Process for the preparation of (s)-(-)-n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine, a duloxetine intermediate |
| 03/18/2009 | CN101389620A Process for obtaining enantiomers of duloxetine precursors |
| 03/18/2009 | CN101386596A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 03/18/2009 | CN100469775C Sulfoxyalkylthiophene compound and process for producing the same |
| 03/17/2009 | US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504433 e.g. (2-Methyl-4-{2-[3-methyl-5-(4-trifluoromethyl-phenyl)-thiophen-2-yl]-propylsulfanyl}-phenoxy)-acetic acid;peroximose proliferator activated receptor; antidiabetic agent,atherosclerosis |
| 03/17/2009 | US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 03/17/2009 | US7504422 Polyamine compounds |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/17/2009 | US7504393 Benzylamine analogues |
| 03/17/2009 | US7504354 [Dimethylsilanediyl(2-methyl-8-phenylbenzo[b]cyclopenta[d]-thien-3-ylidene)2]zirconium(IV) dichloride; for homo- and copolymerization of propylene; useful for producing hard and stiff shaped bodies having high ultimate tensile strength, e.g. fibers, filaments, injection-molded parts, films, plates |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/17/2009 | CA2194064C Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 03/12/2009 | WO2009030962A1 Bicyclic aryl and heteroaryl receptor modulators |